TFRC and acute myeloid leukemia: Cancer cells proliferate indefinitely therefore their expression of CD71 is maintained at a significantly higher level than healthy blood cells at any time of the cell cycle.22 These studies have shown that anti-CD71 can effectively be used to detect acute myeloid leukemia cells23 and acute lymphoblastic leukemia cells24 below the WHO threshold.